Protein components of the blood–brain barrier (BBB) in the mediobasal hypothalamus
暂无分享,去创建一个
[1] H. Heng,et al. Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein/neuropeptide Y neurons for normal energy homeostasis. , 2008, Endocrinology.
[2] J. Pachter,et al. Transcellular transport of CCL2 across brain microvascular endothelial cells , 2008, Journal of neurochemistry.
[3] A. Fukamizu,et al. Impaired placental neovascularization in mice with pregnancy-associated hypertension , 2008, Laboratory Investigation.
[4] H. Münzberg,et al. Differential accessibility of circulating leptin to individual hypothalamic sites. , 2007, Endocrinology.
[5] B. Meister. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight , 2007, Physiology & Behavior.
[6] C. Capobianco,et al. An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis , 2007, Angiogenesis.
[7] M. W. Schwartz,et al. Central nervous system control of food intake and body weight , 2006, Nature.
[8] B. Engelhardt,et al. Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis , 2006, Journal of neuropathology and experimental neurology.
[9] E. Argandoña,et al. Lack of experience-mediated differences in the immunohistochemical expression of blood-brain barrier markers (EBA and GluT-1) during the postnatal development of the rat visual cortex. , 2005, Brain research. Developmental brain research.
[10] S. V. Vinogradov,et al. Effects of Pluronic P85 on GLUT1 and MCT1 Transporters in the Blood-Brain Barrier , 2004, Pharmaceutical Research.
[11] B. Lowell,et al. Leptin Receptor Signaling in POMC Neurons Is Required for Normal Body Weight Homeostasis , 2004, Neuron.
[12] B. Meister,et al. Abnormal cholinergic and GABAergic vascular innervation in the hypothalamic arcuate nucleus of obese tub/tub mice , 2004, Synapse.
[13] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[14] M. Kálmán,et al. Disappearance of the post‐lesional laminin immunopositivity of brain vessels is parallel with the formation of gliovascular junctions and common basal lamina. A double‐labelling immunohistochemical study , 2004, Neuropathology and applied neurobiology.
[15] Michel Demeule,et al. High transcytosis of melanotransferrin (P97) across the blood–brain barrier , 2002, Journal of neurochemistry.
[16] A. K. Shetty,et al. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose–response relationships , 2002, Neuroscience.
[17] Rachel L. Batterham,et al. Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.
[18] A. Shetty,et al. Disruption of the Blood–Brain Barrier and Neuronal Cell Death in Cingulate Cortex, Dentate Gyrus, Thalamus, and Hypothalamus in a Rat Model of Gulf-War Syndrome , 2002, Neurobiology of Disease.
[19] C. Leigh,et al. Electron microscope study of blood–brain barrier opening induced by immunological targeting of the endothelial barrier antigen , 2002, Brain Research.
[20] P. Reilly,et al. Clostridium perfringens Prototoxin-Induced Alteration of Endothelial Barrier Antigen (EBA) Immunoreactivity at the Blood–Brain Barrier (BBB) , 2001, Experimental Neurology.
[21] B. Lin,et al. Quantitative analysis of microvascular alterations in traumatic brain injury by endothelial barrier antigen immunohistochemistry. , 2001, Journal of neurotrauma.
[22] F. Vanderwerf,et al. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. , 2001, Investigative ophthalmology & visual science.
[23] Mounir N. Ghabriel,et al. Immunological targeting of the endothelial barrier antigen (EBA) in vivo leads to opening of the blood–brain barrier , 2000, Brain Research.
[24] W F Ganong,et al. Circumventricular Organs: Definition And Role In The Regulation Of Endocrine And Autonomic Function , 2000, Clinical and experimental pharmacology & physiology.
[25] E. Rodríguez,et al. A second look at the barriers of the medial basal hypothalamus , 2000, Experimental Brain Research.
[26] S. Woods,et al. Central nervous system control of food intake , 2000, Nature.
[27] J. Rømer,et al. Co-Localization of Growth Hormone Secretagogue Receptor and NPY mRNA in the Arcuate Nucleus of the Rat , 1999, Neuroendocrinology.
[28] S. Tsukita,et al. Endothelial Claudin , 1999, The Journal of cell biology.
[29] J. Lawrenson,et al. A comparison of blood-brain barrier and blood-nerve barrier endothelial cell markers , 1999, Anatomy and Embryology.
[30] R. Cone,et al. Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat. , 1999, Endocrinology.
[31] B. Engelhardt,et al. Immunohistochemical localization of the murine transferrin receptor (TfR) on blood–tissue barriers using a novel anti-TfR monoclonal antibody , 1998, Histochemistry and Cell Biology.
[32] S. Vannucci,et al. Glucose transporter proteins in brain: Delivery of glucose to neurons and glia , 1997, Glia.
[33] J. Lawrenson,et al. Differential distribution of an endothelial barrier antigen between the pial and cortical microvessels of the rat , 1997, Brain Research.
[34] W. Banks,et al. Leptin enters the brain by a saturable system independent of insulin , 1996, Peptides.
[35] R. Broadwell,et al. Transcytosis of Protein through the Mammalian Cerebral Epithelium and Endothelium III. Receptor-Mediated Transcytosis through the Blood–Brain Barrier of Blood-Borne Transferrin and Antibody against the Transferrin Receptor , 1996, Experimental Neurology.
[36] J. Krum. Effect of Astroglial Degeneration on Neonatal Blood–Brain Barrier Marker Expression , 1996, Experimental Neurology.
[37] J. Kril,et al. Glial fibrillary acidic protein (GFAP) immunohistochemistry in human cortex: a quantitative study using different antisera , 1996, Neuroscience Letters.
[38] S. Woods,et al. Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice , 1996, Diabetes.
[39] J. Bue-Valleskey,et al. The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.
[40] T. Petrov,et al. Distribution of the tight junction-associated protein ZO-1 in circumventricular organs of the CNS. , 1994, Brain research. Molecular brain research.
[41] G. Perry,et al. Ontogeny of the erythroid/HepG2-type glucose transporter (GLUT-1) in the rat nervous system. , 1993, Brain research. Developmental brain research.
[42] K Kirschfeld,et al. Ectopic expression of ultraviolet-rhodopsins in the blue photoreceptor cells of Drosophila: visual physiology and photochemistry of transgenic animals , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[43] J. Anderson,et al. Localization and differential expression of two isoforms of the tight junction protein ZO-1. , 1992, The American journal of physiology.
[44] H. van Goor,et al. Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[45] T. J. Cunningham,et al. Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain , 1991, The Journal of comparative neurology.
[46] U. Roessmann,et al. The erythrocyte‐type glucose transporter in blood vessels of primary and metastatic brain tumors , 1991, Annals of neurology.
[47] G. Perry,et al. Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[48] O. Ezaki,et al. Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers. , 1990, Biochemical and biophysical research communications.
[49] W. Pardridge,et al. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. , 1990, The Journal of biological chemistry.
[50] R N Kalaria,et al. Glucose transporters are abundant in cells with "occluding" junctions at the blood-eye barriers. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[51] John K. Young,et al. Glucose transporter immunoreactivity in the hypothalamus and area postrema , 1990, Brain Research Bulletin.
[52] W. Pardridge,et al. The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier. , 1990, Biochemical and biophysical research communications.
[53] L. Drewes,et al. Glucose transporter localization in brain using light and electron immunocytochemistry , 1989, Journal of neuroscience research.
[54] L. Sternberger,et al. Cell surface endothelial proteins altered in experimental allergic encephalomyelitis , 1989, Journal of Neuroimmunology.
[55] P. Greengard,et al. DARPP-32, a dopamine- and cyclic AMP-regulated phosphoprotein in tanycytes of the mediobasal hypothalamus: Distribution and relation to dopamine and luteinizing hormone-releasing hormone neurons and other glial elements , 1988, Neuroscience.
[56] L. Sternberger,et al. Blood-brain barrier protein recognized by monoclonal antibody. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[57] W. Pardridge,et al. Blood-brain barrier transcytosis of insulin in developing rabbits , 1987, Brain Research.
[58] G. Gabbiani,et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation , 1986, The Journal of cell biology.
[59] P. Greengard,et al. The hypothalamic arcuate nucleus-median eminence complex: Immunohistochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons , 1986, Brain Research Reviews.
[60] W. Jefferies,et al. Transferrin receptor on endothelium of brain capillaries , 1984, Nature.
[61] P. Greengard,et al. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[62] P. Greengard,et al. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[63] M. Salcman,et al. Brain-blood barrier? Yes and no. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[64] R. Broadwell,et al. Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood , 1976, The Journal of comparative neurology.
[65] Joseph S. Fruton,et al. The Collected Papers of Paul Ehrlich , 1957, The Yale Journal of Biology and Medicine.
[66] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[67] R. Broadwell. Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal , 2004, Acta Neuropathologica.
[68] M. Palkovits. Micro- and Macroscopic Structure, Innervation, and Vasculature of the Hypothalamus , 2000 .
[69] Marc E. Freeman,et al. Neuroendocrinology in Physiology and Medicine , 2000, Humana Press.
[70] Broadwell Rd. Pathways into, through, and around the fluid-brain barriers. , 1992 .
[71] R. Dermietzel,et al. Molecular anatomy of the blood-brain barrier as defined by immunocytochemistry. , 1991, International review of cytology.
[72] J. Panksepp,et al. Anatomy of the hypothalamus , 1979 .
[73] Jaak Panksepp,et al. Handbook of the hypothalamus , 1979 .